Download PDF
Thromb Haemost 1997; 78(02): 840-844
DOI: 10.1055/s-0038-1657638
Rapid Communication
Schattauer GmbH Stuttgart

Physical Activity, Fibrinogen Plasma Level and Gene Polymorphisms in Postmenopausal Women

Rainer Rauramaa
1   The Kuopio Research Institute of Exercise Medicine and Department of Physiology, University of Kuopio, Finland
,
Sari Väisänen
1   The Kuopio Research Institute of Exercise Medicine and Department of Physiology, University of Kuopio, Finland
,
Aulikki Nissinen
2   The Department of Community Health and General Practice, University of Kuopio, Finland
,
Tuomo Rankinen
1   The Kuopio Research Institute of Exercise Medicine and Department of Physiology, University of Kuopio, Finland
,
IIkka Penttilä
3   The Department of Clinical Chemistry, Kuopio University Hospital, Finland
,
Seppo Saarikoski
4   The Department of Obstetrics and Gynaecology, Kuopio University Hospital, Finland
,
Jaakko Tuomilehto
5   The National Public Health Institute, Helsinki, Finland
,
Jacques Gagnon
6   The Physical Activity Sciences Laboratory, Laval University, Quebec, Canada
,
Louis Pérusse
6   The Physical Activity Sciences Laboratory, Laval University, Quebec, Canada
,
Claude Bouchard
6   The Physical Activity Sciences Laboratory, Laval University, Quebec, Canada
› Author Affiliations
Further Information

Publication History

Received 28 1996

Accepted after resubmission 25 March 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The relations between habitual physical activity (PA), fibrinogen gene polymorphisms and plasma fibrinogen were investigated in 191 postmenopausal women. Subjects who reported PA at least 4 times/ week had lower fibrinogen level (3.19 g/1; 95% Cl 3.10; 3.27) than women reporting PA 2-3 times/week (3.43 g/1; 3.29; 3.58) or sedentary subjects (3.64 g/1; 3.33; 3.94). There were no differences in plasma fibrinogen across the α-fibrinogen (Rsal, TaqI) or (β-fibrinogen (Mnll, Bell, Hindlll) genotypes, the frequencies of which were in a Hardy- Weinberg equilibrium. An interaction between Rsal, which was in complete linkage disequilibrium with TaqI, and PA on plasma fibrinogen was observed, even after adjustments for BMI, smoking and medication (p = 0.024). Among women homozygous for the common Rsal allele, the physically most active had lower fibrinogen level (p <0.001) compared to the physically less active subjects. These results suggest that, in postmenopausal women, the relation between physical activity and plasma fibrinogen is modulated by genetic variation in the α-fibrinogen gene.

 

  • References

  • 1 Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-1186
    CrossrefPubMedGoogle Scholar
  • 2 Wilhelmsen L, Svärdsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
    CrossrefPubMedGoogle Scholar
  • 3 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537
    PubMedGoogle Scholar
  • 4 Heinrich J, Balleisen L, Schulte H, Assmann G, van deLoo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59
    CrossrefPubMedGoogle Scholar
  • 5 Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1-12
    CrossrefPubMedGoogle Scholar
  • 6 Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein Ilb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553-1559
    CrossrefPubMedGoogle Scholar
  • 7 Henschen AH. Human fibrinogen – Structural variants and functional sites. Thromb Haemost 1993; 70: 42-47
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Bini A, Fenoglio Jr JJ, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 1989; 09: 109-121
    CrossrefPubMedGoogle Scholar
  • 9 Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterio’scler Thromb Vase Biol 1995; 15: 1263-1268
    PubMedGoogle Scholar
  • 10 Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U. for the Bezafibrate Infarction Prevention (BIP) Study Group. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vase Biol 1996; 16: 351-356
    CrossrefPubMedGoogle Scholar
  • 11 Kant JA, Fomace Jr AJ, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organisation of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad SciUSA 1985; 82: 2344-2348
    CrossrefPubMedGoogle Scholar
  • 12 Rosenson RS, Tangney CC, Hafner JM. Intraindividual variability of fibrinogen levels and cardiovascular risk profile. Arterioscler Thromb 1994; 14: 1928-1932
    CrossrefPubMedGoogle Scholar
  • 13 Hamsten A, Iselius L, de FaireU, Blombäck M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987; 02: 988-991
    PubMedGoogle Scholar
  • 14 Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet 1989; 36: 229-235
    PubMedGoogle Scholar
  • 15 Reed T, Tracy RP, Fabsitz RR. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study. Clin Genet 1994; 45: 71-77
    PubMedGoogle Scholar
  • 16 Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987; 01: 1452-1455
    PubMedGoogle Scholar
  • 17 Fowkes FGR, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 1992; 339: 693-696
    CrossrefPubMedGoogle Scholar
  • 18 Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemo-stas 1993; 70: 915-920
    PubMedGoogle Scholar
  • 19 Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vase Biol 1995; 15: 96-104
    CrossrefPubMedGoogle Scholar
  • 20 Iso H, Folsom AR, Winkelmann JC, Koike K, Harada S, Greenberg B, Sato S, Shimamoto T, Iida M, Komachi Y. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995; 73: 106-111
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Rankinen T, Rauramaa R, Väisänen S, Penttilä I, Saarikoski S, Tuomilehto J, Nissinen A. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women. Atherosclerosis 1993; 102: 181-186
    CrossrefPubMedGoogle Scholar
  • 22 WHO MONICA Project: Risk factors. Int J Epidemiol 1989; 18: S46-S55
    CrossrefPubMed
  • 23 Puska P, Salonen JT, Nissinen A, Tuomilehto J, Vartiainen E, Korhonen H, Tanskanen A, Rönnqvist P, Koskela K, Huttunen J. Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). BMJ 1983; 287: 1840-1844
    CrossrefPubMedGoogle Scholar
  • 24 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. ActaHaemat 1957; 17: 237-246
    PubMedGoogle Scholar
  • 25 Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet 1994; 94: 165-170
    PubMedGoogle Scholar
  • 26 Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A455(Haelll), C/T148(Hindlll/Alul), T/G+1689(Avail), and Bell (p-fibrinogen) and TaqI (α-fibrinogen), and their detection by PCR. Human Mutation 1994; 03: 79-81
    CrossrefPubMedGoogle Scholar
  • 27 Weir BS. Genetic data analysis. Methods for discrete population genetic data. Sinauer Associates, Inc. Publishers; Sunderland, Massachusetts: 1990
    Google Scholar
  • 28 Terwilliger JD, Ott J. Handbook of human genetic linkage. Baltimore’ Johns Hopkins University Press; 1994. pp. 188-198
    Google Scholar
  • 29 Ernst E. Fibrinogen as a cardiovascular risk factor – interrelationship with infections and inflammation. Eur Heart J 1993; 14 K 82-87
    PubMedGoogle Scholar
  • 30 Stefanick ML, Legault C, Tracy RP, Howard G, Kessler CM, Lucas DL, Bush TL. Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the postmenopausal estrogen/progestin interventions (PEPI) study. Arterioscler Thromb Vase Biol 1995; 15: 2085-2093
    CrossrefPubMedGoogle Scholar
  • 31 Stevenson ET, Davy KP, Seals DR. Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women. Arterioscler Thromb Vase Biol 1995; 15: 669-677
    CrossrefPubMedGoogle Scholar
  • 32 Tonstad S, de LangeP, Sivertsen M, Ose L. Physical fitness and fibrinogen levels among hypercholesterolemic postmenopausal women. Nutr Metab Cardiovasc Dis 1995; 5: 93-97
    PubMedGoogle Scholar
  • 33 Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Cambien F. β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Circulation 1996; 93: 440-449
    CrossrefPubMedGoogle Scholar
  • 34 Heinrich J, Funke H, Rust S, Schulte H, Schonfeld R, Kohler E, Assmann G. Impact of polymorphisms in the alpha-and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res 1995; 77: 209-215
    CrossrefPubMedGoogle Scholar
  • 35 de MaatMPM, de BartACW, Hennis BC, Meijer P, Havelaar AC, Mulder PGH, Kluft C. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler Thromb Vase Biol 1996; 16: 1156-1162
    CrossrefPubMedGoogle Scholar
  • 36 Thomas AE, Green FR, Lamlum H, Humphries SE. The association of combined a and p fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers. J Med Genet 1995; 32: 585-589
    CrossrefPubMedGoogle Scholar
  • 37 Connor JM, Fowkes FGR, Wood J, Smith FB, Donnan PT, Lowe GDO. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet 1992; 29: 480-482
    PubMedGoogle Scholar
  • 38 Friedlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibrinogen variability in Israeli families: The Kibbutzim family Study. Am J Hum Genet 1995; 56: 1194-206
    PubMedGoogle Scholar
  • 39 Väisänen S, Rauramaa R, Rankinen T, Gagnon J, Bouchard C. Physical activity, fitness and plasma fibrinogen with reference to fibrinogen genotypes. Med Sci Sports Exerc 1996; 28: 1165-1170
    CrossrefPubMedGoogle Scholar
  • 40 Montgomery HE, Clarkson P, Nwose OM, Mikailidis DP, Jagroop IA, Dollery C, Moult J, Benhizia F, Deanfield J, Jubb M, World M, McEwan JR, Winder A, Humphries S. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the P-fibrinogen gene. Arterioscler Thromb Vase Biol 1996; 16: 386-391
    CrossrefPubMedGoogle Scholar
  • 41 Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with Bβ cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393
    PubMedGoogle Scholar
  • 42 Roy S, Overton O, Redman C. Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J Biol Chem 1994; 269: 691-695
    PubMedGoogle Scholar
  • 43 Collen D, Semeraro N, Tricot JP, Vermylen J. Turnover of fibrinogen, plasminogen, and prothrombin during exercise in man. J Appl Physiol 1977; 42: 865-873
    CrossrefPubMedGoogle Scholar